Clinical Trial Update: DurAVR™ THV EU-EFS [NA]

View source ↗

Summary

This clinical trial update indicates that the DurAVR transcatheter heart valve trial in Europe is not yet recruiting for symptomatic/severe aortic valve stenosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Calcification
• Aortic Valve Disease
• Aortic Valve Insufficiency
• Aortic Valve Stenosis

Drugs mentioned

• DurAVR

Snippet

Sponsor: Anteris Technologies Ltd. | Conditions: Symptomatic Aortic Stenosis, Severe Aortic Valve Stenosis | NA | Status: NOT_YET_RECRUITING